Literature DB >> 7010291

Residual beta-cell function and islet cell antibodies in diabetic children.

J R Crossley, A G James, R B Elliot, C C Berryman, B W Edgar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7010291     DOI： 10.1203/00006450-198101000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN： 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  10 in total

1.  Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

Authors:  M Wallensteen; G Dahlquist; B Persson; M Landin-Olsson; A Lernmark; G Sundkvist; B Thalme
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

2.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

3.  Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes.

Authors:  G Klöppel; C R Drenck; M Oberholzer; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

4.  An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16.

Authors:  A Mustonen; J Ilonen; H K Akerblom; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

5.  Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

Authors:  H J Gjessing; L E Matzen; O K Faber; A Frøland
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

6.  Residual B cell function in diabetic children as determined by urinary C-peptide.

Authors:  J Aurbach-Klipper; R Sharph-Dor; L G Heding; M Karp; Z Laron
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

7.  Residual insulin secretion in insulin dependent diabetes mellitus.

Authors:  S Rogers; M Silink
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

8.  Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.

Authors:  A Mustonen; M Knip; N P Huttunen; R Puukka; M L Käär; H K Akerblom
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

9.  Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.

Authors:  E Schober; G Schernthaner; H Frisch; M Fink
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

10.  Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.

Authors:  H J Yoo; S G Hartling; C Binder
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.